Identification and characterization of lLF2 as a prognostic biomarker in HER2-positive breast cancer using Mendelian randomization and machine learning
{{output}}
Background: HER2-positive breast cancer is an aggressive molecular subtype characterized by high recurrence rates and poor prognosis. Identifying robust biomarkers for prognosis and therapeutic response is essential to improve in... ...
